BR0110450A - Uso de agonistas receptores d4 de dopamina seletivo para tratamento de disfunção sexual - Google Patents

Uso de agonistas receptores d4 de dopamina seletivo para tratamento de disfunção sexual

Info

Publication number
BR0110450A
BR0110450A BR0110450-0A BR0110450A BR0110450A BR 0110450 A BR0110450 A BR 0110450A BR 0110450 A BR0110450 A BR 0110450A BR 0110450 A BR0110450 A BR 0110450A
Authority
BR
Brazil
Prior art keywords
receptor agonists
treatment
sexual dysfunction
selective dopamine
dopamine
Prior art date
Application number
BR0110450-0A
Other languages
English (en)
Inventor
Jorge D Brioni
Teodozyj Kolasa
Gin C Hsieh
Diane L Donnelly-Roberts
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27109879&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0110450(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/985,974 external-priority patent/US20020103105A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR0110450A publication Critical patent/BR0110450A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DE AGONISTAS RECEPTORES D~ 4~ DE DOPAMINA SELETIVO PARA TRATAMENTO DE DISFUNçãO SEXUAL". A presente invenção refere-se ao uso de agonistas receptores D~ 4~ de dopamina seletivo e a composições contendo agonistas receptores D~ 4~ de dopamina seletivo para o tratamento de disfunção sexual.
BR0110450-0A 2000-11-22 2001-11-21 Uso de agonistas receptores d4 de dopamina seletivo para tratamento de disfunção sexual BR0110450A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71831100A 2000-11-22 2000-11-22
US09/985,974 US20020103105A1 (en) 2000-11-22 2001-11-07 Use of selective dopamine D4 receptor agonists for treating sexual dysfunction
PCT/US2001/043139 WO2002041894A2 (en) 2000-11-22 2001-11-21 Selective dopamine d4 receptor agonists for treating sexual dysfunction

Publications (1)

Publication Number Publication Date
BR0110450A true BR0110450A (pt) 2005-02-09

Family

ID=27109879

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110450-0A BR0110450A (pt) 2000-11-22 2001-11-21 Uso de agonistas receptores d4 de dopamina seletivo para tratamento de disfunção sexual

Country Status (25)

Country Link
EP (1) EP1345608B1 (pt)
JP (1) JP2004534725A (pt)
KR (1) KR20030051857A (pt)
CN (1) CN1531434A (pt)
AR (1) AR035600A1 (pt)
AT (1) ATE358483T1 (pt)
AU (2) AU2002226895B2 (pt)
BG (1) BG107810A (pt)
BR (1) BR0110450A (pt)
CA (1) CA2429383A1 (pt)
CZ (1) CZ20031458A3 (pt)
DE (1) DE60127712T2 (pt)
ES (1) ES2284727T3 (pt)
HK (1) HK1059884A1 (pt)
HU (1) HUP0402358A3 (pt)
IL (1) IL155094A0 (pt)
MX (1) MXPA03004547A (pt)
NO (1) NO20032304L (pt)
NZ (1) NZ525086A (pt)
PE (1) PE20020557A1 (pt)
PL (1) PL365890A1 (pt)
SK (1) SK7242003A3 (pt)
TW (1) TWI293254B (pt)
UY (1) UY27031A1 (pt)
WO (1) WO2002041894A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
BR0306625A (pt) * 2002-05-23 2006-04-18 Abbott Lab acetamidas e benzamidas que são úteis no tratamento de disfunção sexual
ES2646326T3 (es) 2005-08-03 2017-12-13 Sprout Pharmaceuticals, Inc. Uso de flibanserina en el tratamiento de la obesidad
CA2626134C (en) 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
DE602007004615D1 (de) 2006-06-30 2010-03-18 Boehringer Ingelheim Pharma Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
AR062320A1 (es) 2006-08-14 2008-10-29 Boehringer Ingelheim Int Formulaciones de flibanserina y metodo para fabricarlas
EA200900270A1 (ru) 2006-08-25 2009-08-28 Бёрингер Ингельхайм Интернациональ Гмбх Системы регулируемого высвобождения и способ их приготовления
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
EP3581567A1 (en) * 2011-04-10 2019-12-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69530988T2 (de) * 1994-08-05 2003-12-04 Pfizer Benzimidazolderivate mit dopaminerger wirkung
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
EP0982030A3 (en) * 1998-08-17 2000-05-10 Pfizer Products Inc. 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
US6291471B1 (en) * 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males

Also Published As

Publication number Publication date
TWI293254B (en) 2008-02-11
AU2002226895B2 (en) 2006-10-12
AR035600A1 (es) 2004-06-16
HK1059884A1 (en) 2004-07-23
KR20030051857A (ko) 2003-06-25
JP2004534725A (ja) 2004-11-18
UY27031A1 (es) 2002-07-31
MXPA03004547A (es) 2004-03-26
NZ525086A (en) 2006-07-28
PE20020557A1 (es) 2002-06-25
DE60127712D1 (de) 2007-05-16
ATE358483T1 (de) 2007-04-15
CA2429383A1 (en) 2002-05-30
WO2002041894A3 (en) 2002-10-17
EP1345608B1 (en) 2007-04-04
HUP0402358A2 (hu) 2005-03-29
AU2689502A (en) 2002-06-03
CN1531434A (zh) 2004-09-22
EP1345608A2 (en) 2003-09-24
NO20032304D0 (no) 2003-05-21
BG107810A (bg) 2004-02-27
NO20032304L (no) 2003-07-15
WO2002041894A2 (en) 2002-05-30
HUP0402358A3 (en) 2009-08-28
CZ20031458A3 (cs) 2004-02-18
PL365890A1 (en) 2005-01-10
IL155094A0 (en) 2003-10-31
SK7242003A3 (en) 2004-01-08
ES2284727T3 (es) 2007-11-16
DE60127712T2 (de) 2007-12-27

Similar Documents

Publication Publication Date Title
PL1620392T3 (pl) Oksymowe pochodne hydroksy-bifenylo-karbaldehydu i ich zastosowania jako środków estrogennych
IL154604A0 (en) Guanidinobenzamides as mc4-r agonists
IL154981A0 (en) Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents
AU7191001A (en) Use of dopamine D<sub>2</sub>/D<sub>3</sub> receptor agonists to treat fibromyalgia
MXPA05009682A (es) Metodos de radiofluorinacion de vectores biologicamente activos.
IL154911A0 (en) Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
BRPI0412975A (pt) espuma penetrante para uso farmacêutico
BR0110450A (pt) Uso de agonistas receptores d4 de dopamina seletivo para tratamento de disfunção sexual
IL142047A0 (en) Mglur5 antagonists for the treatment of pain and anxiety
BR0205812A (pt) Benzimidazois úteis no tratamento da disfunção sexual
HUP0105201A3 (en) The treatment of andropause using pharmaceutical compositions containing estrogen agonists/antagonists and testosterone
BR0011261B1 (pt) composiÇço oral compreendendo perlita, e, uso de perlita.
MXPA04006079A (es) Compuestos para el tratamiento de la disfuncion sexual.
DE60114039D1 (de) Kautschukzusammensetzungen und vulkanisate einschliesslich verzweigter kammpolymere
IT1317861B1 (it) Uso di composti fluorurati per conferire proprieta' release.
MY141606A (en) N-alkoxyalkyl-substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa
IL156174A0 (en) 1,2,4-oxadizaole derivatives as hppar alpha agonists
MY155220A (en) Selective dopamine d4 receptor agonists for treating sexual dysfunction
EP1260221A3 (en) Combination treatment for depression and anxiety
RU2000118409A (ru) Антимутагенное средство
ES1047478U (es) Dispositivo para relaciones sexuales perfeccionado.
ECSP034752A (es) Benzimidazoles utiles en el tratamiento de la dinfuncion sexual
WO2001087861A3 (en) Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators
CL2003002752A1 (es) Compuestos derivados de benzoazolilpiperazinas; composicion farmaceutica; kit farmaceutica; y uso del compuesto para tratar o prevenir el dolor, incontinencia urinaria, ulceras, colon irritable, intestino inflamado, adiccion, entre otras.
ITMI20020314V0 (it) Dispositivo studiato per limitare l'utilizzazione di sigarette sigarie simili

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM O ART.34 "II" DA LPI (LEI 9279, DE 14/05/96), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]